91
To Assess the Safety and Tolerability of an Oral Aripiprazole/Escitalopram Combination Therapy in Participants With Major Depressive Disorder (MDD)
Condition(s):Major Depressive Disorder (MDD)Last Updated:December 22, 2021Terminated
Aripiprazole: 434 Clinical Trials, Page 10 of 44
Hide Studies Not Open or Pending
92
Trial of Aripiprazole Intramuscular Depot (OPC-14597, Lu AF41155) in the Acute Treatment of Adults With Schizophrenia
Condition(s):SchizophreniaLast Updated:February 16, 2015Completed
93
Omega-3 Fatty Acid Adjunctive to Open-Label Aripiprazole for the Treatment of Bipolar Disorder in Children and Adolescents
Condition(s):Pediatric Bipolar DisorderLast Updated:April 6, 2012Terminated
94
Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
Condition(s):Bipolar DisorderLast Updated:January 7, 2015Completed
95
Aripiprazole Once-monthly Versus Paliperidone Palmitate in Adult Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:March 17, 2017Completed
96
Safety and Tolerability Study of Aripiprazole IM Depot in Adult Subjects With Schizophrenia
Condition(s):Schizophrenia; Mental Disorder; Nervous System DiseasesLast Updated:July 1, 2015Completed
97
Aripiprazole Used as Dual Therapy in the Treatement of Patients With Chronic Stable Schizophrenia or Schizoaffective Disorder.
Condition(s):Schizophrenia; Schizoaffective DisorderLast Updated:November 8, 2013Completed
98
Biomarkers in Autism of Aripiprazole and Risperidone Treatment (BAART)
Condition(s):Autistic DisorderLast Updated:September 26, 2018Completed
99
Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
Condition(s):SchizophreniaLast Updated:August 14, 2013Completed
100
Aripiprazole for Methamphetamine Dependence: Double Blind Placebo Trial
Condition(s):Methamphetamine DependenceLast Updated:June 26, 2015Withdrawn